These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1279731)

  • 1. Interactions of prostanoids with the platelet activating factors.
    Mentz P; Mentz G; Giessler C; Mest HJ
    Prostaglandins Leukot Essent Fatty Acids; 1992 Sep; 47(1):13-6. PubMed ID: 1279731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-activating factor-induced coronary constriction in the isolated perfused guinea pig heart and antagonistic effects of the PAF antagonist WEB 2086.
    Felix SB; Steger A; Baumann G; Busch R; Ochsenfeld G; Berdel WE
    J Lipid Mediat; 1990; 2(1):9-20. PubMed ID: 2133268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet activating factor stimulates cyclo-oxygenase activity in guinea pig eosinophils. Concerted biosynthesis of thromboxane A2 and E-series prostaglandins.
    Giembycz MA; Kroegel C; Barnes PJ
    J Immunol; 1990 May; 144(9):3489-97. PubMed ID: 2158510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of nitric oxide and platelet-activating factor in cardiac alterations induced by tumor necrosis factor-alpha in the guinea-pig papillary muscle.
    Alloatti G; Penna C; De Martino A; Montrucchio G; Camussi G
    Cardiovasc Res; 1999 Mar; 41(3):611-9. PubMed ID: 10435033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased prostaglandin I2 and thromboxane A2 production by rat dental pulp after intravenous administration of endotoxin.
    Hirafuji M; Shinoda H
    Arch Oral Biol; 1994 Nov; 39(11):995-1000. PubMed ID: 7695514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of platelet-activating factor on porcine pulmonary blood vessels in vitro.
    Pritze S; Simmet T; Peskar BA
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Oct; 344(4):495-9. PubMed ID: 1766475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between platelet-activating factor and prostanoids during mesenteric ischemia-reperfusion-induced shock in the anesthetized dog.
    Filep JG; Braquet P; Mózes T
    Circ Shock; 1991 Sep; 35(1):1-8. PubMed ID: 1742856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of platelet-activating factor on myocardial contraction and myocardial relaxation of isolated perfused guinea pig hearts.
    Felix SB; Baumann G; Ahmad Z; Hashemi T; Niemczyk M; Berdel WE
    J Cardiovasc Pharmacol; 1990 Nov; 16(5):750-6. PubMed ID: 1703596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Equine peritoneal macrophage production of thromboxane and prostacyclin in response to platelet activating factor and its receptor antagonist SRI 63-441.
    Morris DD; Moore JN
    Circ Shock; 1989 Jun; 28(2):149-58. PubMed ID: 2544315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The platelet-independent release of thromboxane A2 by Paf-acether from guinea-pig lungs involves mechanisms distinct from those for leukotriene.
    Lefort J; Rotilio D; Vargaftig BB
    Br J Pharmacol; 1984 Jul; 82(3):565-75. PubMed ID: 6430375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interference by the novel PAF-acether antagonist WEB 2086 with the bronchopulmonary responses to PAF-acether and to active and passive anaphylactic shock in guinea-pigs.
    Pretolani M; Lefort J; Malanchère E; Vargaftig BB
    Eur J Pharmacol; 1987 Aug; 140(3):311-21. PubMed ID: 3653247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staphylococcal alpha-toxin provokes coronary vasoconstriction and loss in myocardial contractility in perfused rat hearts: role of thromboxane generation.
    Sibelius U; Grandel U; Buerke M; Mueller D; Kiss L; Kraemer HJ; Braun-Dullaeus R; Haberbosch W; Seeger W; Grimminger F
    Circulation; 2000 Jan 4-11; 101(1):78-85. PubMed ID: 10618308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-activating factor raises airway and vascular pressures and induces edema in lungs perfused with platelet-free solution.
    Hamasaki Y; Mojarad M; Saga T; Tai HH; Said SI
    Am Rev Respir Dis; 1984 May; 129(5):742-6. PubMed ID: 6547031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonism of vasoconstriction induced by platelet-activating factor in guinea-pig perfused hearts by selective platelet-activating factor receptor antagonists.
    Piper PJ; Stewart AG
    Br J Pharmacol; 1987 Apr; 90(4):771-83. PubMed ID: 3034369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of PAF on cardiac function and eicosanoid release in the isolated perfused rat heart: comparison between normotensive and spontaneously hypertensive rats.
    Giessler C; Pönicke K; Steinborn C; Brodde OE
    Basic Res Cardiol; 1995; 90(4):337-47. PubMed ID: 8534259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of 5-lipoxygenase and cyclooxygenase blockade on porcine hemodynamics during continuous infusion of platelet-activating factor.
    Olson NC; Kruse-Elliott KT; Johnson LW
    Prostaglandins Leukot Essent Fatty Acids; 1993 Aug; 49(2):549-59. PubMed ID: 8415804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of thromboxane A2 and platelet-activating factor in allergic bronchoconstriction in guinea pig airway in vivo.
    Saito M; Fujimura M; Ogawa H; Matsuda T
    J Lipid Mediat Cell Signal; 1995 Jan; 11(1):1-12. PubMed ID: 7728413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelin-1 and platelet activating factor stimulate thromboxane A2 biosynthesis in rat vascular smooth muscle cells.
    Takayasu-Okishio M; Terashita Z; Kondo K
    Biochem Pharmacol; 1990 Dec; 40(12):2713-7. PubMed ID: 2260994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of platelet activating factor antagonists on arachidonic acid-induced platelet aggregation and TXA2 formation.
    Heinroth-Hoffmann I; Hauser A; Mest HJ
    Prostaglandins Leukot Essent Fatty Acids; 1990 Nov; 41(3):181-2. PubMed ID: 2149184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-activating factor increases vascular resistance in rat hindquarters by thromboxane A2.
    Rizzo A; Taylor AE; Townsley MI; Logsdon P; Khimenko PL; Fletcher JR
    Am J Physiol; 1995 May; 268(5 Pt 2):H1954-8. PubMed ID: 7771545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.